Aequus Pharmaceuticals Inc. reported earnings results for the first quarter ended March 31, 2024. For the first quarter, the company reported net loss was CAD 0.662088 million compared to CAD 0.744323 million a year ago.
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
0.025 CAD | +25.00% | -16.67% | 0.00% |
1st Jan change | Capi. | |
---|---|---|
0.00% | 24.25L | |
+37.74% | 72TCr | |
+34.64% | 59TCr | |
-2.07% | 37TCr | |
+20.25% | 33TCr | |
+2.99% | 28TCr | |
+17.02% | 24TCr | |
+10.09% | 21TCr | |
-4.38% | 21TCr | |
+7.43% | 17TCr |
- Stock Market
- Equities
- AQS Stock
- News Aequus Pharmaceuticals Inc.
- Aequus Pharmaceuticals Inc. Reports Earnings Results for the First Quarter Ended March 31, 2024